Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain

Journal of Neuroscience

Volumn 16, Issue 10, 1996, Pages 3139-3153

  Giulian, Dana ^a   Yu, Jiahan ^a   Li, Xia ^a   Tom, Donald ^a   Li, Jun ^a   Wendt, Elaine ^a   Lin, Shen Nan ^b   Schwarcz, Robert ^c   Noonan, Christine ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

AIDS; brain; dementia; gp120; HIV 1; macrophage; microglia; neurotoxin; NMDA; quinolinic acid

Indexed keywords

EXCITOTOXIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTOXIN; QUINOLINIC ACID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CHICK EMBRYO; CONTROLLED STUDY; FETUS; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MACROPHAGE; MICROGLIA; MONONUCLEAR CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030002044     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-10-03139.1996     Document Type: Article

References (58)

1. Abercrombie M (1946) Estimation of nuclear population from microtome sections. Anat Rec 94:239-247.
2. Achim CL, Heyes MP, Wiley CA (1993) Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brain. J Clin Invest 91:2769-2775.
3. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-57.
4. Asami T, Kagechika H, Hashimoto Y, Shudo K, Miwa A, Kawai N, Nakajima T (1989) Acylpolyamines mimic the action of Joro spider toxin (JSTX) on crustacean muscle glutamate receptors. Biomed Res 10:185-189.
5. Beal MF, Swartz KJ, Hyman BT, Storey E, Finn SF (1991) Aminooxyacetic acid results in excitotoxin lesions by a novel indirect mechanism. J Neurochem 57:1068-1073.
6. Boje KM, Arora PK (1992) Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 587:250-256.
7. Bottenstein JE, Sato GH (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 76:514-517.
8. Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkius KL, Ruff MR, Pert PC (1988) Neuronal cell killing by the envelope protein of HIV and its prevention bv vasoactive intestinal peptide. Nature 335:639-642.
9. Budka H (1989) Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis. Acta Neuropathol 77:225-236.
10. Colton CA, Gilbert DL (1987) Production of superoxide anion by a CNS macrophage, the microglia. FEBS Lett 223:284-288.
11. Denis M (1994) Human monocytes/macrophages: NO or no NO? J Leukoc Biol 55:682-684.
12. Dreyer EB, Kaiser PK, Offermann JT, Lipton SA (1990) HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248:364-367.
13. Epstein LG, Gendelman HE (1993) HIV-1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol 33:429-436.
14. Faulstich ME (1986) AIDS: an overview of CNS complications and neuropsychological sequelae. Int J Neurosci 30:249-254.
15. Fink RP, Heimer L (1967) Two methods for selective silver impregnation of degenerating axons and their synaptic endings in the central nervous system. Brain Res 4:369-374.
16. Foster A, Okuno E, Brougher D, Schwarcz R (1986) A radioenzymatic assay for quinolinic acid. Anal Biochem 158:98-103.
17. Gabuzda DH, Hirsch MS (1987) Neurologic manifestations of infection with human immunodeficiency virus. Ann Intern Med 107:383-391.
18. Gelbard HA, Nottet HS, Swindells S, Jell M, Dzenko KA, Genis P, White R, Wang L, Choi YB, Zhang D (1994) Platelet-activating factor: a candidate human HIV-1-induced neurotoxin. J Virol 68:4628-4635.
19. Gelman BB (1993) Diffuse microgliosis associated with cerebral atrophy in the acquired immunodeficiency syndrome. Ann Neurol 34:65-70.
20. Gendelman HE, Lipton SA, Tardieu M, Epstein L (1994) The neuropathogenesis of HIV-1 infection. J Leukoc Biol 56:389-398.
21. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrachi Y, Volsky DJ (1992) Cytokines and arachidonic metabolites produced during HIV-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 176:1703-1718.
22. Giulian D (1992a) Brain inflammatory cells, neurotoxins, and acquired immunodeficiency syndrome. Fidia Res Found Symp Ser 9:229-234.
23. Giulian D (1992b) Microglia and diseases of the nervous system. Curr Neurol 12:23-54.
24. Giulian D (1995) Microglia and neuron dysfunction. In: Neuroglia (Kettenmann H, Ransom B, eds), pp 671-684. Oxford: Oxford UP.
25. Giulian D, Baker TJ (1986) Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 6:2163-2178.
26. Giulian D, Noonan C, Vaca K (1990) HIV-1-infected mononuclear phagocytes release neurotoxins. Science 250:1593-1595.
27. Giulian D, Wendt E, Vaca K, Noonan C (1993a) The envelope glycoprotein of HIV-1 stimulates monocyte release of neurotoxins. Proc Natl Acad Sci USA 90:2769-2773.
28. Giulian D, Vaca K, Corpuz M (1993b) Brain glia release factors with opposing actions upon neuronal survival. J Neurosci 13:29-37.
29. Giulian D, Leara B, Keenan C, Li J (1994) Phagocytic microglia release cytokines and cytotoxins that regulate survival of astrocytes and neurons in culture. Neurochem Int 25:227-233.
30. Giulian D, Haverkamp LJ, Li J, Karshia WL, Yu J, Tom D, Li X, Kirkpatrick J (1995a) Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem Int 27:119-137.
31. Giulian D, Li J, Bartel S, Broker J, Li X (1995b) Cell surface morphology identifies microglia to be a distinct class of mononuclear phagocytes. J Neurosci 15:7712-7726.
32. Goldstein A, Aronow L, Kalman SM (1974) Principles of drug action. Chap 4, 2nd Ed, pp 301-355. New York: Wiley.
33. Heyes MP, Lackner A (1990) Increased cerebrospinal fluid quinolinic acid, kynurenic acid, and L-kynurenine in acute septicemia. J Neurochem 55:338-341.
34. Heyes MP, Markey SP (1988) Quantification of quinolinic acid in rat brain, whole blood, and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations. Anal Biochem 174:349-359.
35. Heyes MP, Rubinow D, Lane C, Markey SP (1989) Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Ann Neurol 26:275-277.
36. Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AR, Keilp J (1991) Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol 29:202-229.
37. Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJ, Lackner A (1992) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115:1249-1273.
38. Ketzler S, Weis S, Haug H, Budka H (1990) Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol (Berl) 80:92-94.
39. Kornecki E, Ehrlich YH (1988) Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor. Science 240:1792-1794.
40. Jasys VJ, Kelbaugh PR, Nason DM, Phillips D, Rosnack KJ, Saccomano NA, Stroh JG, Volkmann RA (1990) Isolation, structure elucidation, and synthesis of novel hydroxylamine-containing polyamines from the venom of the Agelenopsis aperta spider. J Am Chem Soc 112:6696-6704.
41. Lipton SA (1992a) Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. NeuroReport 3:913-915.
42. Lipton SA (1992b) Models of neuronal injury in AIDS: another role for the NMDA receptor? Trends Neurosci 15:75-79.
43. Mangos JA, Doran T, Aranda-Naranjo B, Rodriguez-Escobar Y, Scott A (1989) Pediatric AIDS: clinical presentation and diagnosis. Tex Med 85:32-34.
44. Masliah E, Ge N, Achim CL, Hansen LA, Wiley CA 1992 Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol 51:585-593.
45. Navia BA, Cho E-S, Petito CK, Price RW (1986a) The AIDS dementia complex II: neuropathology. Ann Neurol 19:525-535.
46. Navia BA, Jordan BD, Price RW (1986b) The AIDS dementia complex. 1. Clinical features. Ann Neurol 19:517-524.
47. Petito CK, Cash KS (1992) Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 32:658-666.
48. Petralia RS, Yokotani N, Wenthold RJ (1994) Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J Neurosci 14:667-696.
49. Pulliam L, Herndier BG, Tang NM, McGrath MS (1991) HIV-1 infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest 87:503-512.
50. Sabatier JM, Vives E, Mabrouk K, Benjouad A, Rochat H, Duval A, Hue B, Bahraoui E (1991) Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol 65:961-967.
51. Saito K, Chen CY, Masana M, Crowley JS, Markey SP, Heyes MP (1993) 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan, and norharmane attenuate quinolinic acid formation by interferon gamma-stimulated monocytes (THP-1 cells). Biochem J 291:11-14.
52. Schwarcz R, Whetsell WO, Mangano RM (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219:316-318.
53. Snider W, Simpson DM, Nielsen S, Gold JW, Metroka CW, Posner JB (1983) Neurological complications of AIDS: analysis, of 50 patients. Ann Neurol 14:403-418.
54. Thery C, Chamak B, Mallat M (1991) Cytotoxic effect of brain macrophages on developing neurons. Eur J Neurosci 3:1155-1164.
55. Walsh J, Todd WP, Carpenter BK, Schwarcz R (1991) 4-Halo-3-hydroxyanthroanilic acids: potent competitive inhibitors of 2-hydroxyanthranilic acid oxygenase in vitro. Biochem Pharmacol 42:985-990.
56. Whetsell WO, Schwarcz R (1989) Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci Lett 97:271-275.
57. Wiley CA, Masliah E, Morey M, Lemeie C, DeTeresa R, Grafe M, Hansen L, Terry R (1991) Neocortical damage during HIV infection. Ann Neurol 29:651-657.
58. Williams K, Dawson VL, Romano C, Dichter MA, Molinoff PB (1990) Characterization of polyamines having agonist, antagonist, an inverse agonist effects at the polyamine recognition site of the NMDA receptor. Neuron 5:199-208.